Clinical Trial

Pleural Fluid Neutrophil Extracellular Traps Exacerbate Disease Severity and Risk of One-year Mortality in Pleural Infection (TORPIDS-3)

Study acronym: TORPIDS-3
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Pleural infection is a severe and complicated disease which is associated with significant morbidity and mortality. People with pleural infection show diverse levels of neutrophil degranulation activity. The investigators examined the biological role of pleural fluid neutrophil extracellular traps in patients with pleural infection. TORPIDS-3 is an observational, International multicohort study.
Trial Details
NCT Number NCT07194915
Lead Sponsor University of Oxford
Collaborators: University of Dundee
Conditions Pleural Infection
Enrollment 326 participants
Start Date 2024-01-09
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-26